Document is current
Any future updates will be listed below
-
Authors
Kishimoto, Shinji
Higashi, Yukihito
Imai, Takumi
Eguchi, Kazuo
Fukumoto, Kazuo
Tomiyama, Hirofumi
Maemura, Koji
Tanaka, Atsushi
Node, Koichi
,
Murohara, Toyoaki
Kitakaze, Masafumi
Nishio, Yoshihiko
Inoue, Teruo
Ohishi, Mitsuru
Kario, Kazuomi
Sata, Masataka
Shimabukuro, Michio
Shimizu, Wataru
Jinnouchi, Hideaki
Taguchi, Isao
Suzuki, Makoto
Ando, Shinichi
Kamiya, Haruo
Sakamoto, Tomohiro
Teragawa, Hiroki
Nanasato, Mamoru
Matsuhisa, Munehide
Ako, Junya
Aso, Yoshimasa
Ishihara, Masaharu
Kitagawa, Kazuo
Yamashina, Akira
Ishizu, Tomoko
Ikehara, Yumi
Ueda, Shinichiro
Takamori, Ayako
Yoshida, Hisako
Mori, Miki
Yamaguchi, Kaori
Asaka, Machiko
Kaneko, Tetsuya
Sakuma, Masashi
Toyoda, Shigeru
Nasuno, Takahisa
Kageyama, Michiya
Teruo, Jojima
Toshie, Iijima
Kishi, Haruka
Yamada, Hirotsugu
Kusunose, Kenya
Fukuda, Daiju
Yagi, Shusuke
Yamaguchi, Koji
Ise, Takayuki
Kawabata, Yutaka
Kuroda, Akio
Akasaki, Yuichi
Kurano, Mihoko
Hoshide, Satoshi
Komori, Takahiro
Kabutoya, Tomoyuki
Ogata, Yukiyo
Koide, Yuji
Kawano, Hiroaki
Ikeda, Satoshi
Fukae, Satoki
Koga, Seiji
Kajikawa, Masato
Maruhashi, Tatsuya
Kubota, Yoshiaki
Shibata, Yoshisato
Kuriyama, Nehiro
Nakamura, Ikuko
Hironori, Kanemitsu
Takase, Bonpei
Orita, Yuichi
Oshita, Chikage
Uchimura, Yuko
Yoshida, Ruka
Yoshida, Yukihiko
Suzuki, Hirohiko
Ogura, Yasuhiro
Maeda, Mayuho
Takenaka, Masaki
Hayashi, Takumi
Hirose, Mirai
Hisauchi, Itaru
Kadokami, Toshiaki
Nakamura, Ryo
Kanda, Junji
Matsunaga, Kazuo
Hoshiga, Masaaki
Sohmiya, Koichi
Kanzaki, Yumiko
Koyosue, Arihiro
Uehara, Hiroki
Miyagi, Naoto
Chinen, Toshiya
Nakamura, Kentaro
Nago, Chikashi
Chiba, Suguru
Hatano, Sho
Gima, Yoshikatsu
Abe, Masami
Ajioka, Masayoshi
Asano, Hiroshi
Nakashima, Yoshihiro
Osanai, Hiroyuki
Kanbara, Takahiro
Sakamoto, Yusuke
Oguri, Mitsutoshi
Ohguchi, Shiou
Takahara, Kunihiko
Izumi, Kazuhiro
Yasuda, Kenichiro
Kudo, Akihiro
Machii, Noritaka
Morimoto, Ryota
Bando, Yasuko
Okumura, Takahiro
Kondo, Toru
Miura, Shin-ichiro
Shiga, Yuhei
Mirii, Joji
Sugihara, Makoto
Arimura, Tadaaki
Nakano, Junko
Sakamoto, Tomohiro
Kodama, Kazuhisa
Ohte, Nobuyuki
Sugiura, Tomonori
Wakami, Kazuaki
Takemoto, Yasuhiko
Yoshiyama, Minoru
Shuto, Taichi
Okada, Yosuke
Tanaka, Kenichi
Sonoda, Satomi
Tokutsu, Akemi
Otsuka, Takashi
Uemura, Fumi
Koikawa, Kenji
Miyazaki, Megumi
Umikawa, Maiko
Narisawa, Manabu
Furuta, Machi
Minami, Hiroshi
Doi, Masaru
Sugimoto, Kazuhiro
Suzuki, Susumu
Kurozumi, Akira
Nishio, Kosuke
-
Funding
Funding for this research was provided by:
Astellas Pharma Inc. Japan
- License Information
-
More Information
Article History
Received: 7 April 2023
Accepted: 11 May 2023
First Online: 20 May 2023
Declarations
:
: The study protocol for this sub-analysis was approved by the Ethics Committee of Saga University Hospital (2022-09-02) and registered (jRCT1071220089). All the individuals provided written informed consent to participate in the study. All methods were performed in accordance with the Declaration of Helsinki and relevant guidelines and regulations in Japan.
: All authors have read and approved the submission of the manuscript.
: Competing interestsYH received honoraria from Astellas, AstraZeneca, MSD, Boehringer Ingelheim, Takeda, Bayer, Novo Nordisk, Fuji, Mochida, Eli Lilly, Teijin Pharma, Daiichi Sankyo, Otsuka, Kowa, Novartis, and Mitsubishi Tanabe and a research grant from Kao. TI received lecture fees from JCR Pharmaceuticals and Kyowa Kirin and outsourcing fees from the Organization for Clinical Medicine Promotion. KM received honoraria from Daiichi Sankyo, Novartis, Takeda, and Pfizer and a research grant from Daiichi Sankyo and Biotronik. AT received honoraria from Boehringer Ingelheim and research funding from GlaxoSmithKline, Takeda, Bristol, Myers Squibb, and Novo Nordisk. NK has received honoraria from AstraZeneca, Bayer Yakuhin, Boehringer Ingelheim Japan, Daiichi Sankyo, Eli Lilly Japan, Mitsubishi Tanabe Pharma, MSD, Novartis Pharma, Ono Pharmaceutical, Otsuka; Research grants from　Asahi Kasei, Astellas, Boehringer Ingelheim Japan, Fujiyakuhin, Mitsubishi Tanabe Pharma, Mochida Pharmaceutical, Novartis Pharma, and Teijin Pharma; and scholarships from Bayer Yakuhin, Japan Lifeline, and Teijin Pharma. The authors declare that they have no competing interests.
